Cargando…
Sharing of Clinical Trial Data and Samples: The Cancer Patient Perspective
Introduction: Today, many initiatives and papers are devoted to clinical trial data (and to a lesser extent sample) sharing. Journal editors, pharmaceutical companies, funding agencies, governmental organizations, regulators, and clinical investigators have been debating the legal, ethical, and soci...
Autores principales: | Broes, Stefanie, Verbaanderd, Ciska, Casteels, Minne, Lacombe, Denis, Huys, Isabelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026937/ https://www.ncbi.nlm.nih.gov/pubmed/32118017 http://dx.doi.org/10.3389/fmed.2020.00033 |
Ejemplares similares
-
Toward a Tiered Model to Share Clinical Trial Data and Samples in Precision Oncology
por: Broes, Stefanie, et al.
Publicado: (2018) -
Past, Current, and Future Cancer Clinical Research Collaborations: The Case of the European Organisation for Research and Treatment of Cancer
por: Broes, Stefanie, et al.
Publicado: (2020) -
Exploring new uses for existing drugs: innovative mechanisms to fund independent clinical research
por: Verbaanderd, Ciska, et al.
Publicado: (2021) -
On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients
por: Verbaanderd, Ciska, et al.
Publicado: (2020) -
Industry Perspectives on Market Access of Innovative Drugs: The Relevance for Oncology Drugs
por: Pauwels, Kim, et al.
Publicado: (2016)